Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (UP0) Q2 2023 Earnings Report

0 Followers

CH:UP0 Q2 2023 EPS Results

Actual EPS
-CHF 1.88
Consensus EPS
-CHF 1.75
Beat/Miss
Missed by -CHF 0.13
One Year Ago EPS
-CHF 1.89

CH:UP0 Q2 2023 Revenue Results

Actual Revenue
CHF 90.47M
Expected Revenue
CHF 87.54M
Beat/Miss
Beat by +CHF 2.93M
YoY Revenue Growth
+21.23%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/03/2023
Time
After Close
Conference Call
Thursday, August 3, 2023
CH:UP0 Upcoming Earnings

Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

CH:UP0 Q2 2023 Earnings Call
0:00 / 0:00

Q2 2023 Earnings Slide Deck

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:UP0 Earnings History

CH:UP0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)2.00--1.08――
Nov 03, 20262026 (Q3)-0.92-0.97-1.5135.91% (+0.54)
Aug 04, 20262026 (Q2)-1.04-0.75-0.9823.08% (+0.23)
May 05, 20262026 (Q1)-1.24-1.54-1.31-17.20% (-0.23)
Feb 12, 20262025 (Q4)-0.91-1.08-1.167.19% (+0.08)
Nov 04, 20252025 (Q3)-1.03-1.51-1.17-29.29% (-0.34)
Aug 05, 20252025 (Q2)-1.08-0.98-1.2723.03% (+0.29)
May 06, 20252025 (Q1)-1.33-1.31-1.722.66% (+0.38)
Feb 13, 20252024 (Q4)-1.09-1.16-1.278.55% (+0.11)
Nov 05, 20242024 (Q3)-1.24-1.17-1.8637.22% (+0.69)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed